First-in-Human Study of [211At]NaAt as Targeted α-Therapy in Patients with Radioiodine-Refractory Thyroid Cancer (Alpha-T1 Trial).
Saved in:
| Title: | First-in-Human Study of [211At]NaAt as Targeted α-Therapy in Patients with Radioiodine-Refractory Thyroid Cancer (Alpha-T1 Trial). |
|---|---|
| Authors: | Watabe T; Department of Radiology, Graduate School of Medicine, University of Osaka, Osaka, Japan; watabe.tadashi.med@osaka-u.ac.jp.; Institute for Radiation Sciences, University of Osaka, Osaka, Japan., Mukai K; Department of Metabolic Medicine, Graduate School of Medicine, University of Osaka, Osaka, Japan., Naka S; Department of Pharmacy, University of Osaka Hospital, Osaka, Japan., Sasaki H; Department of Medical Technology, University of Osaka Hospital, Osaka, Japan., Kamiya T; Department of Medical Technology, University of Osaka Hospital, Osaka, Japan., Hayakawa T; Department of Metabolic Medicine, Graduate School of Medicine, University of Osaka, Osaka, Japan., Fukuhara A; Department of Metabolic Medicine, Graduate School of Medicine, University of Osaka, Osaka, Japan., Takano T; Department of Metabolic Medicine, Graduate School of Medicine, University of Osaka, Osaka, Japan., Shirakami Y; Institute for Radiation Sciences, University of Osaka, Osaka, Japan., Ooe K; Institute for Radiation Sciences, University of Osaka, Osaka, Japan., Shigeno S; Department of Gastroenterology and Hepatology, Graduate School of Medicine, University of Osaka, Osaka, Japan.; Medical Innovation Center, University of Osaka Hospital, Osaka, Japan., Okamura S; Medical Innovation Center, University of Osaka Hospital, Osaka, Japan., Masumura K; Medical Innovation Center, University of Osaka Hospital, Osaka, Japan., Hida E; Department of Biostatistics and Data Science, Graduate School of Medicine, University of Osaka, Osaka, Japan; and., Haba H; RIKEN Nishina Center for Accelerator-Based Science, Wako, Japan., Toyoshima A; Institute for Radiation Sciences, University of Osaka, Osaka, Japan., Isohashi K; Department of Radiology, Graduate School of Medicine, University of Osaka, Osaka, Japan., Shimomura I; Department of Metabolic Medicine, Graduate School of Medicine, University of Osaka, Osaka, Japan., Tomiyama N; Department of Radiology, Graduate School of Medicine, University of Osaka, Osaka, Japan.; Institute for Radiation Sciences, University of Osaka, Osaka, Japan. |
| Source: | Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2025 Dec 03; Vol. 66 (12), pp. 1941-1947. Date of Electronic Publication: 2025 Dec 03. |
| Publication Type: | Journal Article; Clinical Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
